Format

Send to

Choose Destination
Ann Neurol. 1999 Jul;46(1):132-4.

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: reporting extended results from phase III clinical trials. National Multiple Sclerosis Society Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Author information

1
UCSF/MT Zion Multiple Sclerosis Center, San Francisco, CA 95115, USA.
PMID:
10401793
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center